How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in GIPR (rs1800437), and other peptide-pathway genes to may help provide context about individual predisposition toward GLP-1 sensitivity and metabolic responsiveness
Aim for blood pressure targets your doctor recommends, often below 130/80 Treat sleep apnea if diagnosed, as it affects blood flow to the optic nerve Maintain healthy cholesterol levels to reduce overall vascular risk Avoid smoking, which significantly worsens diabetic retinopathy Treatment Options for GLP-1-Related Eye Complications If you develop mild worsening of diabetic retinopathy during early GLP-1 treatment, we may recommend observation with more frequent monitoring rather than immediate intervention
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Mounjaro), chronic weight management (under the brand name Zepbound), and most recently in 2024, for the treatment of adults with moderate-to-severe obstructive sleep apnea who have obesity or are overweight with at least one weight-related comorbidity
Sip consistently throughout the day rather than drinking large amounts at once
Telehealth platforms like Doctronic.ai provide convenient access to medical professionals who can help you manage side effects without delay
Fatima, who is 38 years old, was diagnosed with ADHD 12 years ago